Trade Therapy

Page 165

Deepening Cooperation on Medical Goods and Services Trade

NOTES 1. The service delivery “modes of supply” referred to in this chapter and throughout the volume refer to the World Trade Organization (WTO) General Agreement on Trade in Services (GATS) modes: (1) cross-border supply, (2) consumption abroad, (3) commercial presence, and (4) presence of natural persons. 2. See, for example, the APEC resource page, “APEC COVID-19 Economic Response and Recovery Initiatives” (last updated February 2022), https://www.apec.org/covid-19/apec-covid-19​ -economic-response-and-recovery-initiatives. 3. The general exceptions provision of the General Agreement on Tariffs and Trade (GATT), art. XX, permits restrictions if necessary to protect human, animal, or plant life or health (art. XX[b]) or that are “essential to the acquisition or distribution of products in general or local short supply [p]rovided that any such measures shall be consistent with the principle that all contracting parties are entitled to an equitable share of the international supply of such products, and that any such measures, which are inconsistent with the other provisions of the Agreement shall be discontinued as soon as the conditions giving rise to them have ceased to exist” (art. XX[j]). In all these cases, measures may not be applied in a manner that would constitute (a) a means of arbitrary or unjustifiable discrimination between countries where the same conditions prevail, or (b) a disguised restriction on international trade. (Although the WTO is the successor to the GATT, the original GATT text [GATT 1947] remains in effect under the WTO framework, subject to the modifications of GATT 1994.) 4. The EU treaties permit restrictions on intra-EU trade and other types of cross-border movement if member states deem these to be necessary to address emergencies and safeguard national public health and safety. 5. See, for example, “International Travel Restrictions by Country” (web page), Kayak.com (updated May 13, 2022): https://www.kayak.com/travel-restrictions?origin=CD. 6. During the Uruguay Round negotiations (1986–94), some major trading partners agreed to the so-called “Agreement on Pharmaceuticals” or “Pharma,” through which participating countries agreed to eliminate tariffs on pharmaceutical products, including final products and chemical intermediates used for their production. The concessions were transcribed into WTO schedules and hence the tariff elimination applied on a most-favored-nation basis. In addition, participants also agreed to periodically review the Pharma to update and expand the list of items covered (last review in 2010). Also, in 2015, as part of the Expansion of the Information Technology Agreement (ITA Expansion), 53 WTO members, including several developing countries, agreed to eliminate tariffs on some high-technology products, including some medical equipment. 7. For more about quantitative restrictions, see the discussion of GATT 1994 (art. XI) on the WTO website: https://www.wto.org/english/tratop_e/markacc_e/qr_e.htm. 8. See “WTO Members’ Notifications on COVID-19” on the WTO website: https://www.wto.org​ /­english/tratop_e/covid19_e/notifications_e.htm. 9. See, for instance, G-20 (2020) and WTO (2021a). 10. “Developing countries,” when referred to in the WTO context, are those that declare themselves as such. The WTO does not define “developing” or “developed” countries. However, other WTO members may challenge a member’s decision to make use of WTO provisions available to developing countries. See “Who Are the Developing Countries in the WTO?” on the WTO website: https://www.wto.org/english/tratop_e/devel_e/d1who_e.htm. 11. See, for instance, a proposal made by a group of WTO Members to the Trade Facilitation Committee (WTO 2022b). A recommendation of the G-20’s Trade and Investment Working Group, made in May 2020, focused on similar areas, highlighting prearrival processing, separation of release from payments, and expedited shipments (G-20 2020). It also called for speeding up and streamlining customs procedures in line with the TFA. 12. See, for instance, the Declaration on Facilitating the Movement of Essential Goods by the APEC Ministers Responsible for Trade (MRT): https://www.apec.org/Meeting-Papers/Sectoral​ -Ministerial-Meetings/Trade/2020_MRT/Annex-A.

149


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

response for future pandemics

18min
pages 177-187

Notes

11min
pages 165-168

References

12min
pages 169-174

3.2 Low levels of GATS commitments in medical services trade

1min
page 147

commitments than in GATS

15min
pages 148-154

Cooperation beyond trade agreements for global health security

22min
pages 155-164

3.3 Potential commitments to bolster governance of trade policy in global crises

20min
pages 131-139

Trade policy cooperation to contribute to global health security

3min
pages 127-128

3.5 Traceability and illicit trade in medical products in Africa

5min
pages 145-146

B3.4.2 Types of health technology transfer programs reported by WTO developed country members under TRIPS Agreement, art. 66.2, 2018–20

5min
pages 142-144

3.2 Pricing policies for medical goods in the context of international trade

6min
pages 124-126

3.1 RTA cooperation during the COVID-19 pandemic

6min
pages 121-123

References

12min
pages 114-118

Policies affecting medical goods and services trade during the COVID-19 pandemic

2min
page 96

the onset of the COVID-19 pandemic (excluding China), January 2020 to March 2022

5min
pages 108-110

Notes

8min
pages 111-113

2.11 NRA decisions on WHO-EUL COVID-19 vaccines, December 2020 to February 2022

8min
pages 104-107

2.7 Government support measures for the medical goods sector predated the pandemic

6min
pages 93-95

2.4 Trade in medical services faces many trade barriers

5min
pages 88-90

References

8min
pages 71-74

2.2 WTO-notified quantitative restrictions, by type and member income group, 2018–19

3min
pages 80-81

2.3 Progress on implementation commitments under the WTO Trade Facilitation Agreement

10min
pages 82-86

1.22 The vaccine value chains

3min
pages 68-69

2.2 Development of export-oriented medical services in selected countries

2min
page 87

1.17 Exports of PPE soared early in the COVID-19 pandemic

0
page 63

Notes

2min
page 70

1.11 Trade in medical services hit US$78.6 billion in 2019

1min
page 56

1.3 Recent FDI trends in medical goods and services

2min
page 46

Personnel—and the blurred boundaries between trade in medical services and migration of health workers

5min
pages 43-44

1.6 MNCs’ contribution to global value added and exports varies by industry

3min
pages 50-51

Patterns in medical goods and services trade before the pandemic

2min
page 52

B1.1.1 Private health insurance schemes as a share of total health expenditure in selected countries, 2019

3min
pages 41-42

1.1 Access to health care: The role of (trade in) health insurance services

2min
page 40

Drivers of trade in medical goods and services

2min
page 36

of medical goods and services, leading to concentration

8min
pages 32-35

Notes

1min
page 23

1 Trade and trade-related policy actions to improve prevention, preparedness, and

2min
page 20

Deepening cooperation on medical goods and services trade

4min
pages 21-22

Stronger trade systems for better global health security

1min
page 25

References

1min
page 24

Organization of the report

1min
page 26

Reference

0
pages 27-28

The medical goods and services trade: Relevance, characteristics, and welfare implications

1min
page 29
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.